[1]韩佳睿,张 苹,张 媛.迟发性运动障碍与DNA甲基化之间关系的研究进展[J].医学信息,2018,(20):32-34,41.[doi:10.3969/j.issn.1006-1959.2018.20.010]
 HAN Jia-rui,ZHANG Ping,ZHANG Yuan.Advances in Research on the Relationship between Tardive Dyskinesia and DNA Methylation[J].Medical Information,2018,(20):32-34,41.[doi:10.3969/j.issn.1006-1959.2018.20.010]
点击复制

迟发性运动障碍与DNA甲基化之间关系的研究进展()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2018年20期
页码:
32-34,41
栏目:
综述
出版日期:
2018-10-15

文章信息/Info

Title:
Advances in Research on the Relationship between Tardive Dyskinesia and DNA Methylation
文章编号:
1006-1959(2018)20-0032-04
作者:
韩佳睿1张 苹2张 媛1
1.内蒙古医科大学,内蒙古 呼和浩特 010000;2.北京回龙观医院,北京 100000
Author(s):
HAN Jia-rui1ZHANG Ping2ZHANG Yuan1
1.Inner Mongolia Medical University,Hohhot 010000,Inner Mongolia,China; 2.Beijing Huilongguan Hospital,Beijing 100000,China
关键词:
DNA甲基化精神分裂症迟发性运动障碍
Keywords:
DNA methylationSchizophreniaTardive dyskinesia
分类号:
R741.02
DOI:
10.3969/j.issn.1006-1959.2018.20.010
文献标志码:
A
摘要:
DNA甲基化是最常见的表观遗传学修饰之一,异常的甲基化影响基因的转录和表达。有研究表明DNA甲基化可能在精神疾病的发生机制中发挥着很大的作用。本文通过综述迟发性运动障碍的研究进展及DNA甲基化可能发挥的作用,为预测TD的发生发展及临床治疗和预防提供理论依据。
Abstract:
DNA methylation is one of the most common epigenetic modifications,and abnormal methylation affects gene transcription and expression.Studies have shown that DNA methylation may play a large role in the mechanism of mental illness.This article provides a theoretical basis for predicting the occurrence and development of TD and clinical treatment and prevention by reviewing the research progress of tardive dyskinesia and the possible role of DNA methylation.

参考文献/References:

[1]Lanning RK,Zai CC,Müller DJ.Pharmacogenetics of tardive dyskinesia:an updated review of the literature[J].Pharmacogenomics,2016,17(12):1339-1351. [2]Caligiuri MP,Teulings HL,Dean CE,et al.A Quantitative Measure of Handwriting Dysfluency for Assessing Tardive Dyskinesia[J].Journal of Clinical Psychopharmacology,2015,35(2):168-174. [3]王宁,谭云龙,杨甫德,等.精神分裂症伴发迟发性运动障碍的血清S100B蛋白浓度研究[J].中国神经精神疾病杂志,2011,37(9):550-553. [4]王坚.中枢神经系统运动障碍的诊断和处理[J].神经病学与神经康复学杂志,2010,7(3):187-189. [5]Peralta V,Campos MS,De Jalón EG,et al.Motor behavior abnormalities in drug-naive patients with schizophrenia spectrum disorders[J].Schizophrenia Research,2010,117(2-3):187-188. [6]Aquino CC,Lang AE.Tardive dyskinesia syndromes:current concepts [J].Parkinsonism&Related Disorders,2014,20(Suppl 1):S113-S117. [7]Rana AQ,Chaudry ZM,Blanchet PJ.New and emerging treatments for symptomatic tardive dyskinesia[J].Drug Design Development&Therapy,2013,7(default):1329-1340. [8]杨志明,高烨,熊文,等.迟发性运动障碍关联因素的研究综述[J].中国实用医药,2009,4(36):236-238. [9]Andreassen OA,Finsen B,Ostergaard K,et al.The relationship between oral dyskinesias produced by long-term haloperidol treatment, the density of striatal preproenkephalin messenger RNA and enkephalin peptide,and the number of striatal neurons expressing preproenkephalin messenger RNA in rats[J].Neuroscience,1999,88(1):27-35. [10]王崴,亢万虎.迟发性运动障碍的相关问题回顾[J].中国健康心理学杂志,2004,12(4):318-320. [11]Tsai G,Goff DC,Chang RW,et al.Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia[J].Am J Psychiatry,1998,155(9):1207-1213. [12]Mehanna R,Jankovic J.Movement disorders in cerebrovascular disease[J].Lancet Neurology,2013,12(6):597. [13]Ellingrod VL,Schultz SK,Arndt S.Association between cytochrome P4502D6(CYP2D6)genotype,antipsychotic exposure, and abnormal involuntary movement scale(AIMS)score[J].Psychiatr Genet,2000,10(1):9-11. [14]Lam LC,Garcia-Barcelo MM,Ungvari GS,et al.Cytochrome P450 2D6 genotyping and association with tardive dyskinesia in Chinese schizophrenic patients [J].Pharmacopsychiatry,2001,34(6):238. [15]Eiselt R,Domanski TL,Zibat A,et al.Identification and functional characterization of eight CYP3A4 protein variants [J].Pharmacogenetics,2001,11(5):447. [16]Li H,Tan Y,Wang Z,et al.Association study on tardive dyskinesia and polymorphisms in COMT and MAOA in Chinese population[J].Psychiatric Genetics,2013,23(4):176. [17]Dean B,Pavey G,Thomas D,et al.Cortical serotonin 7,1D and 1F receptors:Effects of schizophrenia,suicide and antipsychotic drug treatment[J].Schizophrenia Research,2006,88(1):265-274. [18]Inada T,Koga M,Ishiguro H,et al.Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced,treatment-resistant tardive dyskinesia[J].Pharmacogenetics&Genomics,2008,18(4):317. [19]Bird A.Perceptions of epigenetics[J].Nature,2007,447(7143):396-398. [20]Csoka AB,Szyf M.Epigenetic side-effects of common pharmaceuticals:A potential new field in medicine and pharmacology[J].Medical Hypotheses,2009,73(5):770. [21]Furuta Y,Kobayashi I.Mobility of DNA sequence recognition domains in DNA methyltransferases suggests epigenetics-driven adaptive evolution[J].Mobile Genetic Elements,2012,2(6):292-296. [22]Olson CO,Zachariah RM,Ezeonwuka CD,et al.Brain Region-Specific Expression of MeCP2 Isoforms Correlates with DNA Methylation within Mecp2 Regulatory Elements[J].Plos One,2014,9(3):e90645. [23]张苹,李艳丽,安会梅,等.精神分裂症伴迟发性运动障碍患者基因甲基化谱的初步构建[J].中华精神科杂志,2018,51(1): [24]Marcucci G,Yan P,Maharry K,et al.Epigenetics meets genetics in acute myeloid leukemia:clinical impact of a novel seven-gene score [J].Journal of Clinical Oncology,2015,32(6):548-556. [25]Sandoval J,Heyn H,Moran S,et al.Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome[J].Epigenetics,2016,6(6):692-702. [26]冯磊光,曹鸿雁,祁萍萍,等.精神分裂症患者外周血液中Reelin蛋白的表达[J].国际检验医学杂志,2014(10):1291-1292. [27]BNsch D,Wunschel M,Lenz B,et al.Methylation matters Decreased methylation status of genomic DNA in the blood of schizophrenic twins [J].Psychiatry Research,2012,198(3):533-537. [28]Mill J,Tang T,Kaminsky Z,et al.Epigenomic profiling reveals DNA-methylation changes associated with major psychosis[J].American Journal of Human Genetics,2008,82(3):696-711. [29]Petronis A,Gottesman II,Kan P,et al.Monozygotic Twins Exhibit Numerous Epigenetic Differences:Clues to Twin Discordance[J].Schizophrenia Bulletin,2003,29(1):169-178. [30]Ruzicka WB,Subburaju S,Benes FM.Circuit- and Diagnosis-Specific DNA Methylation Changes at γ-Aminobutyric Acid-Related Genes in Postmortem Human Hippocampus in Schizophrenia and Bipolar Disorder[J].Jama Psychiatry,2015,72(6):541. [31]Boyadjieva N,Varadinova M.Epigenetics of psychoactive drugs[J].Journal of Pharmacy&Pharmacology,2012,64(10):1349-1358.

相似文献/References:

[1]邹超杰,程宇琪.肠道微生物在精神分裂症中的研究进展[J].医学信息,2018,(02):29.[doi:10.3969/j.issn.1006-1959.2018.02.011]
 ZOU Chao-jie,CHENG Yu-qi.Progress in the Study of Intestinal Microorganism in Schizophrenia[J].Medical Information,2018,(20):29.[doi:10.3969/j.issn.1006-1959.2018.02.011]
[2]张 健,江 芮.生活技能训练对精神分裂症缓解期患者日常生活能力的影响[J].医学信息,2018,(03):118.[doi:10.3969/j.issn.1006-1959.2018.03.040]
 ZHANG Jian,JIANG Rui.Effect of Life Skills Training on Daily Living Ability of Patients with Schizophrenia in Remission Staged[J].Medical Information,2018,(20):118.[doi:10.3969/j.issn.1006-1959.2018.03.040]
[3]沈雪梅.齐拉西酮与奥氮平治疗首发精神分裂症 疗效及糖脂代谢的影响观察[J].医学信息,2018,(06):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
 SHEN XUE-mei.The Effect of Ziprasidone and Olanzapine in the Treatment of First Episode Schizophrenia and the Effect of Glycolipid Metabolism[J].Medical Information,2018,(20):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
[4]张益勋,胡逸萍,钟穗航,等.DNA甲基化在病理性瘢痕中的作用研究[J].医学信息,2018,(09):46.[doi:10.3969/j.issn.1006-1959.2018.09.015]
 ZHANG Yi-xun,HU Yi-ping,ZHONG Sui-hang,et al.Study on the Role of DNA Methylation in Pathological Scars[J].Medical Information,2018,(20):46.[doi:10.3969/j.issn.1006-1959.2018.09.015]
[5]陈功琦,梁道博.利培酮联合舍曲林治疗精神分裂症阴性症状 疗效和安全性的Meta分析[J].医学信息,2018,(10):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
 CHEN Gong-qi,LIANG Dao-bo.Meta Analysis of Efficacy and Safety of Risperidone Combined with Sertraline in the Treatment of Schizophrenia with Negative Symptoms[J].Medical Information,2018,(20):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
[6]孙占娟.精神分裂症患者的认知康复治疗进展[J].医学信息,2018,(13):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
 SUN Zhan-juan.Progress in Cognitive Rehabilitation Therapy of Schizophrenia Patients[J].Medical Information,2018,(20):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
[7]吴金丽.阿立哌唑的临床应用[J].医学信息,2018,(14):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
 WU Jin-li.Clinical Application of Aripiprazole[J].Medical Information,2018,(20):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
[8]宋典雄.激励理论指导下的护理干预对精神分裂症患者的影响[J].医学信息,2018,(18):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
 SONG Dian-xiong.The Effect of Nursing Intervention under the Guidance of Motivation Theory on Patients with Schizophrenia[J].Medical Information,2018,(20):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
[9]凌 梅,刘静芳.精神分裂症患者研究伙伴的相关研究进展[J].医学信息,2018,(19):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]
 LING Mei,LIU Jing-fang.Progress in Research on Research Partners in Patients with Schizophrenia[J].Medical Information,2018,(20):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]

更新日期/Last Update: 2018-11-09